Congress ramps up its scrutiny of drug compounding, putting FDA in a bind - STAT

Congress ramps up its scrutiny of drug compounding, putting FDA in a bind - STAT

With safety and cash at stake, a squabble over drug compounding puts the FDA in a bind

By NICHOLAS FLORKO @NicholasFlorko

OCTOBER 10, 2018